CTP354, also known as C-21191, a novel deuterated subtype-selective GABA(A) modulator. CTP may be potentially useful for treatment of neuropathic pain, spasticity and anxiety disorders. GABAA receptors are found in the nervous system and, when activated, reduce the transmission of certain nerve signals. Several classes of widely used drugs target GABAA receptors, including benzodiazepines, but do not have the receptor subtype selectivity of CTP-354.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | CTP354 |
Iupac 化学名称 | CTP354 |
同义词 | CTP-354; CTP 354; C-21191; C 21191; C21191 |
英文同义词 | CTP-354; CTP 354; C-21191; C 21191; C21191 |
分子式 | C19H10D9F2N7O |
分子量 | 408.46072 |
InChiKey | |
InChi | |
Cas号 | 1213669-91-0 |
相关CAS号 | |
外观性状 | crystalline solid |
纯度 | 98% |
存储 | 3 years -20ºCpowder |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |